期刊文献+

硫酸氨基葡萄糖联合依托考昔治疗膝关节骨性关节炎的临床研究 被引量:24

Clinical research of glucosamine sulfate combined with etoricoxib for the treatment of knee osteoarthritis
下载PDF
导出
摘要 目的研究硫酸氨基葡萄糖联合依托考昔治疗膝关节骨性关节炎的疗效以及安全性。方法将2013年9月至2014年9月于我院骨科门诊确诊为膝关节骨性关节炎的150例患者按随机数字表法分成依托考昔组、硫酸氨基葡萄糖组和联合组,每组50例,分别给予依托考昔、硫酸氨基葡萄糖、两种药物联合用药治疗6周。于用药2周和6周时采用西安大略和麦克马斯特大学(the Western Ontario and Mc Master Universities,WOMAC)骨关节炎指数评估疗效并观察不良反应。结果 11例因不良反应退出试验,6例失访,最终133例完成试验且随访资料完整,其中依托考昔组44例,硫酸氨基葡萄糖组43例,联合组46例。治疗2周后,依托考昔组和联合组的WOMAC指数较治疗前有显著改善,其中联合组的改善优于依托考昔组(P<0.05);依托考昔组、硫酸氨基葡萄糖组、联合组的不良反应例数分别为2例、1例和2例。治疗6周后,3组患者的WOMAC指数均优于治疗前(均P<0.05),其中联合组优于依托考昔组和硫酸氨基葡萄糖组(P<0.05),硫酸氨基葡萄糖组优于依托考昔组(P<0.05);3组各发生2例不良反应。结论硫酸氨基葡萄糖联合依托考昔治疗膝关节骨性关节炎比单独使用依托考昔或硫酸氨基葡萄糖的疗效好、起效快,值得临床推广。 Objective To study the effectiveness and security of glucosamine sulfate combined withetoricoxib in the treatment of knee osteoarthritis. Methods Cases of 150 patients with knee osteoarthritis inOrthopaedic Clinic of our hospital from September 2013 to September 2014 were randomly divided into 3groups in accordance with the random number table. The patients in each group were treated with differentdrugs for 6 weeks and followed up at 2nd and 6th week, respectively. The etoricoxib group was administeredorally with etoricoxib, glucosamine sulfate group was given orally with glucosamine sulfate, and combinationgroup was given orally with etoricoxib and glucosamine sulfate. Western Ontario and Mc Master Universities(WOMAC) osteoarthritis index was used to evaluate the effectiveness. Adverse reactions during the treatmentwere recorded. Results Eleven patients withdrew from the study due to adverse reactions, 6 cases were lost,and 133 cases completed the test and had complete follow-up data, including 44 cases in etoricoxib group, 43 cases in glucosamine sulfate group, and 46 cases in combination group. After 2 weeks, effectiveness of bothetoricoxib group and combination group were more satisfactfory than that pre-treatment(P〈0.05), whereas glu-cosamine sulfate group had no improvement compared to pre-treatment(P〈0.05). Effectiveness in combinationgroup was more satisfactory than etoricoxib group(P〈0.05). Adverse reactions occurred in 5 cases. After 6weeks of treatment, effectiveness in all 3 groups were significantly better than that of pre-treatment(P〉0.05). Ef-fectiveness in combination group was significantly better than that in etoricoxib group and glucosamine sulfategroup(P〈0.05), and effectiveness in glucosamine group was better than that in etoricoxib group(P〈0.05). Sixcases of adverse reactions were recorded. Conclusion Glucosamine sulfate combined with etoricoxib shows ex-cellent curative effects on knee osteoarthritis with rapid relief and good security than etoricoxibor or glucos-amine sulfate used alone, and worthwhile for spreading in clinical practice.
出处 《骨科》 CAS 2016年第3期190-194,共5页 ORTHOPAEDICS
基金 国家自然科学基金(31070831)
关键词 骨关节炎 药物疗法 联合 依托考昔 硫酸氨基葡萄糖 Osteoarthritis knee Drug therapy combination Etoricoxib Glucosamine sulfate
  • 相关文献

参考文献21

  • 1陈禾凤,杨婉花.骨关节炎慢作用药物及软骨保护药的研究进展[J].医药导报,2014,33(5):645-649. 被引量:7
  • 2Lane NE, Brandt K, Hawker G, et al. OARSI-FDA initiative: defin- ing the disease state of osteoarthritis [J]. Osteoarthritis Cartilage, 2011, 19(5): 478-482.
  • 3Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice [J]. Lancet, 2011, 377(9783): 2115-2126.
  • 4Pereira D, Peleteire B, Arafijo J, et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic re- view[J]. Osteoarthritis Cartilage, 2011, 19(11): 1270-1285.
  • 5骨关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(6):416-419. 被引量:1379
  • 6Moyer RF, Ratneswaran A, Beier F, et al. Osteoarthritis year in re- view 2014: mechanics-basic and clinical studies in osteoarthritis [J ]. Osteoarthritis Cartilage, 2014, 22(12): 1989-2002.
  • 7Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically im- portant patient relevant outcomes to anti-rheumatic drug therapy in patients with osteoa_,Mu4tis of the hip or knee [J]. J Rheumatol, 1988, 15(12): 1833-1840.
  • 8Fernandes L, Hagen KB, Bijlsma JW, et al. EULAR recommenda- tions for the non-pharmacological core management of hip and knee osteoarthritis[J]. Ann Rheum Dis, 2013, 72(7): 1125-1135.
  • 9Bruy~re O, Cooper C, Pelletier JP, et al. An algorithm recommenda- tion for the management of knee osteoarthritis in Europe and inter- nationally: a report from a task force of the European Society forClinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)[J]. Semin Arthritis Rheum, 2014, 44(3): 253-263.
  • 10McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guide- lines for the non-surgical management of knee osteoarthritis [J]. Osteoarthritis Cartilage, 2014, 22(3): 363-388.

二级参考文献42

  • 1孙钢,张磊,张洪美,陈卫衡,顾力军,赵铁军.膝骨性关节炎分级治疗的疗效分析[J].中国骨伤,2004,17(6):332-334. 被引量:64
  • 2唐福林,张奉春,郑文洁,李军,栗占国,苏茵,吴东海,马丽,周惠琼,黄烽,张江林,周乙雄,徐辉.双醋瑞因治疗膝骨关节炎的疗效与安全性多中心对照研究[J].中华风湿病学杂志,2005,9(7):421-424. 被引量:62
  • 3邱贵兴,翁习生,张克,周乙雄,娄思权,王以朋,李为,张洪,刘岩.盐酸/硫酸氨基葡萄糖治疗骨关节炎的平行对照临床研究[J].中华医学杂志,2005,85(43):3067-3070. 被引量:93
  • 4张建,毛怡芬,邵强.硫酸氨基葡萄糖治疗髌骨软化症的临床观察[J].中国医药,2006,1(4):234-235. 被引量:15
  • 5Zacher J,Feldman D,Gerli R,et al.A comparison of the thera-peutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis[J].Curr Med Res Opin,2003,19(8):725-736.
  • 6Loren L,Sean PC,Byron C,et al.Assessment of upper gastro-intestinal safety of etoricoxib and diclofenac in patients with os-teoarthritis and rheumatoid arthritis in the Multinational Etori-coxib and Diclofenac Arthritis Long-term(MEDAL)pro-gramme:a randomised comparison[J].Lancet,2007,369(9560):465-473.
  • 7Reginster JY,Malmstrom K,Mehta A,et al.Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two,138-week randomised studies of patients with osteoarthritis[J].Ann Rheum Dis,2007,66(7):945-951.
  • 8Matsumoto AK,Cavanaugh Jr.Etoricoxib[J].Drugs Today(Barc),2004,40(5):395-414.
  • 9Cochrane DJ,Jarvis B,Keating GM.Etoricoxib[J].Drugs,2002,62(18):2637-2651.
  • 10Chang DJ,Desjardins PJ,King TR,et al.The analgesic efficacy of etoricoxib compared with oxycodone/acetamino-phen in an acute postoperative pain model:a randomized,double-blind clinical trial[J].Anesth Analg,2004,99(3):807-815.

共引文献1434

同被引文献230

引证文献24

二级引证文献161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部